Emil J Freireich, MD, Oral History Interview, July 23, 2001
Files
Loading...
Description
Major topics covered:
- Personal and educational background;
- Research: the continuous flow-blood separator; innovations in chemotherapy and combination therapy ;
- Collaborations with Dr. Emil Frei, III;
- The Department of Developmental Therapeutics;
- Building the culture of clinical research; training clinical researchers and physician-scientists ;
- History of cancer medicine, clinical research, translational research and education
Interview Chapters
Chapter 01: Growing Up in Chicago with Unusual Opportunities
Chapter 03: On to a Fellowship in Boston and to Hematology
Chapter 04: Oncology Research at a New Hospital at the National Institutes of Health
Chapter 05: Treating Leukemia at the NIH
Chapter 06: The First Systematic Studies of Chemotherapy for Leukemia
Chapter 07: Treating Hemorrhage in Pediatric Leukemia Patients
Chapter 08: A Research Controversy: Treating Hemorrhage in Childhood Leukemia
Identifier
FreireicEJ_01_20010723
Publication Date
7-23-2001
Publisher
The Making Cancer History® Voices Oral History Collection, The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Topics Covered
University of Texas MD Anderson Cancer Center, UT MD Anderson Cancer Center, University of Texas System. M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute at Houston, University of Texas M.D. Anderson Cancer Center, M.D. Anderson Hospital and Tumor Institute
Disciplines
History of Science, Technology, and Medicine | Oncology | Oral History
Recommended Citation
Freireich, Emil J. MD and Brunet, Lesley W., "Emil J Freireich, MD, Oral History Interview, July 23, 2001" (2001). Interview Sessions. 23.
https://openworks.mdanderson.org/mchv_interviewsessions/23
Conditions Governing Access
Open
About the Interview
About the Interview Subject
Dr. Emil J Freireich (b. 16 March 1927, in Chicago, Illinois) came to MD Anderson in 1965 to serve as Chief of Research (Hematology) in the Department of Development Therapeutics. He was appointed Professor in the Department of Leukemia in the Division of Cancer Medicine.
A pioneer in clinical oncology research and the development of new treatments, Dr. Freireich is best known for developing an effective treatment –effectively a cure-- for childhood acute lymphoblastic leukemia. Freireich worked closely with Emil Frei, MD, and the collaborators developed the first combination chemotherapy treatments shown to be effective against childhood leukemia.
Dr. Freireich served as head of MD Anderson’s Department of Developmental Therapeutics from 1972-1983, when he became Chairman of the Department of Hematology (1983-1985). He served as Director of the Adult Leukemia Research Program (1985-2015). He served as Special Medical Education Director of Educational Programs in the Division of Academic Affairs (2000-2015). In 2014, Dr. Freireich was honored as a Fellow of the American Association for Cancer Research. He retired in 2016.